Research Programs

The Sokol Institute houses faculty and researchers studying subjects relevant to human health and disease as well as supporting research in important global health issues such as AIDS and malaria.

Current research programs underway include:

• Development of small molecule inhibitors of a novel malarial p38 MAP kinase homolog(s) with therapeutic potential.  Dr. John Siekierka, Dr. Fina Liotta, Dr. James Dyer and Dr. Tyler Curiel (The San Antonio Cancer Institute)
  
  
• Development of small molecule inhibitors against metallo-b-lactamase to combat antibiotic resistance.  Dr. Jeffrey Toney.  Collaborators:  Prof. John Buynak/Southern Methodist University and Prof. James Spencer/University of Bristol, UK.
  
  
• Isolation of dietary components as potential therapeutics against Type 2 diabetes.  Dr. Jeffrey Toney.  Collaborators: Prof. Shahla Wunderlich and Prof. Charles Feldman, Health and Nutrition Sciences, Montclair State.